Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sai Parenteral'sBOM:544742 +5.09%14 PB Ratio is 11.91 as of Aug. 09, 2026, which is 44% below its 10-year median of 21.22. GuruFocus rates BOM:544742 with a GF Score™ of 14/100. The stock has 7 warning signs investors should review. Among 924 Drug Manufacturers companies, Sai Parenteral's ranks worse than 93.61% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-09), Sai Parenteral's's share price is ₹568.95. Sai Parenteral's's Book Value per Share for the quarter that ended in Sep. 2025 was ₹47.78. Hence, Sai Parenteral's's PB Ratio of today is 11.91.
Good Sign:
Sai Parenteral's Ltd stock PB Ratio (=11.92) is close to 1-year low of 11.92.
The historical rank and industry rank for Sai Parenteral's's PB Ratio or its related term are showing as below:
BOM:544742'
s PB Ratio Range Over the Past 10 Years
Min: 11.92 Med: 21.22 Max: 24.51
Current: 11.92
During the past 3 years, Sai Parenteral's's highest PB Ratio was 24.51. The lowest was 11.92. And the median was 21.22.
BOM:544742's PB Ratio is ranked worse than 93.61% of 924
companies
in the Drug Manufacturers industry
Industry Median: 1.95
vs BOM:544742: 11.92
During the past 12 months, Sai Parenteral's's average Book Value Per Share Growth Rate was 183.20% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Sai Parenteral's PB Ratio Related Terms
Sai Parenteral's PB Ratio Historical Data
* Premium members only.
The historical data trend for Sai Parenteral's's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sai Parenteral's PB Ratio Chart
Sai Parenteral's Annual Data
Trend
Mar23
Mar24
Mar25
PB Ratio
0.00
0.00
0.00
Sai Parenteral's Semi-Annual Data
Mar23
Mar24
Mar25
Sep25
PB Ratio
0.00
0.00
0.00
0.00
BOM:544742 vs LLY, JNJ, ABBV: PB Ratio Comparison
For the Drug Manufacturers - General subindustry, Sai Parenteral's's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sai Parenteral's PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sai Parenteral's's PB Ratio distribution charts can be found below:
* The bar in red indicates where Sai Parenteral's's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Sai Parenteral's (BOM:544742) has a PB Ratio of 11.91 as of Aug. 09, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sai Parenteral's and its competitors. This is 44% below median its historical median of 21.22. Over the past decade, Sai Parenteral's' PB Ratio has ranged from 11.92 to 24.51. According to the industry distribution chart, Sai Parenteral's ranks #865 out of 924 companies in the Drug Manufacturers industry, placing it in the top 93.6%.
Is Sai Parenteral's' PB Ratio too high?
Sai Parenteral's' current PB Ratio of 11.91 is 44% below median its 10-year median of 21.22. Over the past 10 years, this metric has ranged from a low of 11.92 to a high of 24.51. The Drug Manufacturers industry median PB Ratio is 1.95. Sai Parenteral's' value of 11.91 is 510.8% above this industry median. Based on the distribution chart, Sai Parenteral's ranks #865 out of 924 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Sai Parenteral's has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Sai Parenteral's' PB Ratio compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Sai Parenteral's ranks #865 out of 924 companies for PB Ratio. This places Sai Parenteral's in the lower half of its industry. The industry median PB Ratio is 1.95. Sai Parenteral's' value of 11.91 is 510.8% above this benchmark. Historically, Sai Parenteral's' own PB Ratio has ranged from 11.92 to 24.51 over the past decade. While the company's 10-year median is 21.22 vs. the industry median of 1.95, Sai Parenteral's has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.95, based on 924 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sai Parenteral's's current PB Ratio of 11.91 is 510.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Sai Parenteral's and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sai Parenteral's's current PB Ratio is 11.91, which is 44% below median its own 10-year median of 21.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sai Parenteral's stock overvalued right now?
Sai Parenteral's (BOM:544742) has a current PB Ratio of 11.91. The current PB Ratio is 11.91, which is 44% below median its 10-year median of 21.22 and 510.8% above the Drug Manufacturers industry median of 1.95. Sai Parenteral's' overall GF Score™ is 14/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Sai Parenteral's (BOM:544742), the current PB Ratio is 11.91 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sai Parenteral's Ltd is a diversified pharmaceutical formulations company. Its business is organised in two verticals: (i) Branded Generic Formulations: Through the branded generics portfolio, it serves the domestic market with formulations across multiple therapeutic areas. and (ii) Contract Development and Manufacturing Organisation (CDMO): It provides CDMO services to pharmaceutical companies, supporting activities from product development to commercial manufacturing. Its product portfolio includes cardiovascular care, neuropsychiatry, anti-diabetic therapy, respiratory health, antibiotics, gastroenterology, vitamins, etc. The majority of the company's revenue is derived from the Branded Generic Formulations business.
14GF Score
Get the complete analysis for BOM:544742
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544742 has been successfully added to your 
